This inventor holds 5 USPTO granted patents. Top assignees: Smithkline Beecham (Cork) Ltd, Sb Pharmco Puerto Rico Inc.. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Christopher Werner: Innovator in Pharmaceutical Chemistry
Introduction
Christopher Werner is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for cardiovascular conditions. With a total of 5 patents to his name, Werner's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents, Werner has developed carvedilol phosphate salts and/or solvates thereof, along with corresponding compositions and methods of treatment. This invention relates to novel crystalline forms of carvedilol dihydrogen phosphate, which is a dihydrogen phosphate salt of a specific compound. These salts and/or solvates are utilized in treating hypertension, congestive heart failure, and angina, showcasing Werner's commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, Christopher Werner has worked with prominent companies in the pharmaceutical industry. Notable employers include SmithKline Beecham Ltd and Sb Pharmco Puerto Rico Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in drug development.
Collaborations
Werner has collaborated with several professionals in his field, including Christopher S. Brook and Wei Chen. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Christopher Werner stands out as a dedicated inventor in the pharmaceutical sector, with a focus on improving treatments for serious health conditions. His contributions through patents and collaborations reflect his commitment to innovation and the betterment of medical science.